Concepts (132)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Carcinoma, Merkel Cell | 22 | 2024 | 328 | 5.030 |
Why?
|
Skin Neoplasms | 25 | 2024 | 5812 | 1.820 |
Why?
|
Polyomavirus Infections | 5 | 2024 | 194 | 0.790 |
Why?
|
Lymphoma, Mantle-Cell | 1 | 2023 | 237 | 0.740 |
Why?
|
Tumor Virus Infections | 4 | 2024 | 438 | 0.590 |
Why?
|
Antibodies, Viral | 1 | 2024 | 3150 | 0.420 |
Why?
|
Carcinoma, Squamous Cell | 5 | 2024 | 4020 | 0.270 |
Why?
|
Neoplasm Staging | 4 | 2024 | 11116 | 0.190 |
Why?
|
Neoplasm Recurrence, Local | 5 | 2024 | 9277 | 0.170 |
Why?
|
Neoplasm, Residual | 1 | 2024 | 1008 | 0.160 |
Why?
|
Prognosis | 7 | 2024 | 29600 | 0.160 |
Why?
|
Proto-Oncogene Proteins c-bcl-6 | 1 | 2019 | 191 | 0.160 |
Why?
|
Chromosomes, Human, Pair 3 | 1 | 2019 | 322 | 0.150 |
Why?
|
Aged, 80 and over | 10 | 2024 | 58894 | 0.140 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 2007 | 1405 | 0.140 |
Why?
|
Keratin-17 | 1 | 2016 | 26 | 0.130 |
Why?
|
Lymphatic Metastasis | 1 | 2024 | 2913 | 0.130 |
Why?
|
Acneiform Eruptions | 1 | 2014 | 4 | 0.120 |
Why?
|
Anilides | 1 | 2018 | 411 | 0.120 |
Why?
|
Retrospective Studies | 11 | 2024 | 80566 | 0.120 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 1 | 2019 | 899 | 0.120 |
Why?
|
Skin | 3 | 2023 | 4473 | 0.110 |
Why?
|
Neoplasm Metastasis | 1 | 2024 | 4910 | 0.110 |
Why?
|
Neoadjuvant Therapy | 1 | 2024 | 2827 | 0.100 |
Why?
|
Lymph Nodes | 1 | 2023 | 3461 | 0.100 |
Why?
|
Disease Susceptibility | 1 | 2019 | 1788 | 0.100 |
Why?
|
Humans | 31 | 2024 | 760617 | 0.100 |
Why?
|
Aged | 13 | 2024 | 169042 | 0.100 |
Why?
|
Drug Eruptions | 1 | 2014 | 335 | 0.090 |
Why?
|
Middle Aged | 13 | 2024 | 220584 | 0.090 |
Why?
|
Disease Progression | 2 | 2024 | 13495 | 0.080 |
Why?
|
Sentinel Lymph Node Biopsy | 1 | 2014 | 732 | 0.080 |
Why?
|
Host-Pathogen Interactions | 1 | 2017 | 1454 | 0.080 |
Why?
|
Liver Neoplasms | 1 | 2024 | 4308 | 0.080 |
Why?
|
Disease Management | 1 | 2019 | 2506 | 0.080 |
Why?
|
Carcinoma, Ductal, Breast | 1 | 2014 | 1084 | 0.070 |
Why?
|
Combined Modality Therapy | 1 | 2019 | 8516 | 0.070 |
Why?
|
Male | 13 | 2024 | 360358 | 0.070 |
Why?
|
Female | 15 | 2024 | 392148 | 0.070 |
Why?
|
Pyridines | 1 | 2018 | 2874 | 0.060 |
Why?
|
Drug Resistance, Neoplasm | 2 | 2017 | 5304 | 0.060 |
Why?
|
Neoplasm Proteins | 1 | 2016 | 3607 | 0.060 |
Why?
|
Diagnosis, Differential | 1 | 2019 | 12966 | 0.050 |
Why?
|
Survival Analysis | 3 | 2020 | 10073 | 0.050 |
Why?
|
Fatal Outcome | 1 | 2007 | 1835 | 0.050 |
Why?
|
Antigens, Viral, Tumor | 1 | 2022 | 153 | 0.050 |
Why?
|
Mutation | 3 | 2023 | 30016 | 0.050 |
Why?
|
DNA-Binding Proteins | 1 | 2019 | 9586 | 0.050 |
Why?
|
Adult | 8 | 2024 | 220969 | 0.050 |
Why?
|
Phenotype | 1 | 2019 | 16571 | 0.050 |
Why?
|
Mohs Surgery | 1 | 2023 | 222 | 0.040 |
Why?
|
Mice, Inbred NOD | 2 | 2016 | 1827 | 0.040 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2016 | 8542 | 0.040 |
Why?
|
Transcription Factors | 1 | 2019 | 12116 | 0.040 |
Why?
|
Mice, SCID | 2 | 2016 | 2625 | 0.040 |
Why?
|
Polyomavirus | 1 | 2020 | 234 | 0.040 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2013 | 3077 | 0.040 |
Why?
|
Kaplan-Meier Estimate | 2 | 2020 | 6474 | 0.040 |
Why?
|
Gene Expression Regulation | 1 | 2017 | 11874 | 0.040 |
Why?
|
Adenocarcinoma | 1 | 2016 | 6340 | 0.040 |
Why?
|
Epigenomics | 1 | 2023 | 942 | 0.040 |
Why?
|
Breast Neoplasms | 2 | 2015 | 20988 | 0.040 |
Why?
|
Positron-Emission Tomography | 1 | 2014 | 6483 | 0.040 |
Why?
|
Brain Neoplasms | 1 | 2018 | 9026 | 0.030 |
Why?
|
Time-Lapse Imaging | 1 | 2017 | 194 | 0.030 |
Why?
|
Immunotherapy | 2 | 2024 | 4642 | 0.030 |
Why?
|
Flow Cytometry | 2 | 2017 | 5863 | 0.030 |
Why?
|
Interleukin Receptor Common gamma Subunit | 1 | 2016 | 86 | 0.030 |
Why?
|
Spheroids, Cellular | 1 | 2017 | 329 | 0.030 |
Why?
|
Reactive Oxygen Species | 1 | 2024 | 2137 | 0.030 |
Why?
|
Multidrug Resistance-Associated Proteins | 1 | 2016 | 105 | 0.030 |
Why?
|
T-Lymphocytes | 1 | 2013 | 10175 | 0.030 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2020 | 1784 | 0.030 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2024 | 2057 | 0.030 |
Why?
|
Benzoyl Peroxide | 1 | 2014 | 22 | 0.030 |
Why?
|
Virus Integration | 1 | 2017 | 304 | 0.030 |
Why?
|
DNA, Neoplasm | 1 | 2020 | 1743 | 0.030 |
Why?
|
Neoplasms | 1 | 2023 | 22131 | 0.030 |
Why?
|
Etoposide | 1 | 2016 | 634 | 0.030 |
Why?
|
Clindamycin | 1 | 2014 | 139 | 0.030 |
Why?
|
Minocycline | 1 | 2014 | 169 | 0.030 |
Why?
|
Immunohistochemistry | 2 | 2017 | 11069 | 0.030 |
Why?
|
DNA, Viral | 1 | 2020 | 2195 | 0.030 |
Why?
|
Carboplatin | 1 | 2016 | 793 | 0.030 |
Why?
|
Geriatric Assessment | 1 | 2020 | 1411 | 0.030 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2023 | 2872 | 0.030 |
Why?
|
Immunophenotyping | 1 | 2017 | 1865 | 0.030 |
Why?
|
Administration, Topical | 1 | 2014 | 703 | 0.030 |
Why?
|
Interleukin-15 | 1 | 2013 | 185 | 0.020 |
Why?
|
Neoplasm Transplantation | 1 | 2016 | 2010 | 0.020 |
Why?
|
Interleukin-2 Receptor alpha Subunit | 1 | 2013 | 306 | 0.020 |
Why?
|
Neurosurgery | 1 | 2018 | 679 | 0.020 |
Why?
|
Radiotherapy | 1 | 2018 | 1497 | 0.020 |
Why?
|
Microfluidic Analytical Techniques | 1 | 2017 | 799 | 0.020 |
Why?
|
Antigens, Differentiation, T-Lymphocyte | 1 | 2013 | 897 | 0.020 |
Why?
|
Cytokines | 2 | 2017 | 7373 | 0.020 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2018 | 1626 | 0.020 |
Why?
|
DNA Copy Number Variations | 1 | 2019 | 2020 | 0.020 |
Why?
|
Cell Line, Tumor | 2 | 2017 | 16967 | 0.020 |
Why?
|
Cell Culture Techniques | 1 | 2017 | 1662 | 0.020 |
Why?
|
Tumor Cells, Cultured | 1 | 2017 | 6126 | 0.020 |
Why?
|
Lectins, C-Type | 1 | 2013 | 584 | 0.020 |
Why?
|
Cohort Studies | 2 | 2024 | 41457 | 0.020 |
Why?
|
Cell Line | 1 | 2023 | 15576 | 0.020 |
Why?
|
Epigenesis, Genetic | 1 | 2022 | 3794 | 0.020 |
Why?
|
Cell Proliferation | 2 | 2016 | 10432 | 0.020 |
Why?
|
Proportional Hazards Models | 1 | 2023 | 12447 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2018 | 5239 | 0.020 |
Why?
|
Prospective Studies | 2 | 2024 | 54360 | 0.020 |
Why?
|
Genetic Testing | 1 | 2020 | 3533 | 0.020 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2019 | 3634 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 1 | 2014 | 36402 | 0.020 |
Why?
|
Interleukin-2 | 1 | 2013 | 1887 | 0.020 |
Why?
|
Comorbidity | 1 | 2020 | 10505 | 0.020 |
Why?
|
Forkhead Transcription Factors | 1 | 2013 | 1614 | 0.020 |
Why?
|
Transplantation, Heterologous | 1 | 2013 | 2382 | 0.010 |
Why?
|
Radiography | 1 | 2015 | 6961 | 0.010 |
Why?
|
Mice | 3 | 2017 | 81368 | 0.010 |
Why?
|
Logistic Models | 1 | 2019 | 13245 | 0.010 |
Why?
|
Receptor, erbB-2 | 1 | 2014 | 2553 | 0.010 |
Why?
|
Treatment Outcome | 2 | 2020 | 64568 | 0.010 |
Why?
|
Ultrasonography | 1 | 2015 | 5964 | 0.010 |
Why?
|
Antigens, CD | 1 | 2013 | 3998 | 0.010 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2022 | 11736 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2017 | 9417 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2016 | 14389 | 0.010 |
Why?
|
Animals | 3 | 2017 | 168201 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2013 | 18937 | 0.010 |
Why?
|
Antineoplastic Agents | 1 | 2016 | 13635 | 0.010 |
Why?
|
Child | 1 | 2020 | 80079 | 0.010 |
Why?
|
Adolescent | 1 | 2020 | 88234 | 0.010 |
Why?
|
Signal Transduction | 1 | 2013 | 23416 | 0.010 |
Why?
|
Concepts
(132)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(102)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_